The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses

被引:30
|
作者
Wei, X
Liang, C
Götte, M
Wainberg, MA
机构
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Expt Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada
关键词
HIV-1 reverse transcriptase; initiation; tRNA(Lys3); M184V;
D O I
10.1097/00002030-200212060-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To study the ability of HIV constructs containing the M184V substitution in reverse transcriptase (RT), which causes resistance to lamivudine, to evolve mutations that compensate for deletions within the HIV genome. Methods: Viruses containing deletions in non-coding regions of the viral genome were examined in tissue culture to see whether the additional presence of M184V delays the reestablishment of wild-type replication kinetics. Potential compensatory mutations were identified by sequencing, and site-directed mutagenesis was carried out to confirm the biological relevance of such substitutions. The rate of initiation of reverse transcription was measured using either recombinant wild-type RT or RT containing M184V. Results: M184V-containing viruses were unable to undergo compensatory mutagenesis to reestablish wild-type replication kinetics, whereas viruses that did not contain M184V were able to mutate extensively. This ability was demonstrated most extensively in viruses deleted of an 'A-rich loop', located upstream of the primer-binding site, which is involved in initiation of reverse transcription. The rate of such initiation was severely diminished in virus containing the RT enzyme carrying the M184V substitution. This inhibitory effect was significantly enhanced in a biochemical system that included both the M184V mutant enzyme and a viral DNA template that contained the deletion in the A-rich loop. Conclusions: These findings provide further biological and biochemical evidence that M184V-containing viruses are impaired in replication fitness. Viruses that had the A-rich-loop deleted were able to reestablish replication ability quickly in the wild-type RT, which provides further evidence for the plasticity of the HIV genome. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:2391 / 2398
页数:8
相关论文
共 50 条
  • [31] Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance
    Buckton, A. J.
    Prabhu, D.
    Motamed, C.
    Harris, R. J.
    Hill, C.
    Murphy, G.
    Parry, J. V.
    Johnson, J. A.
    Lowndes, C. M.
    Gill, N.
    Pillay, D.
    Cane, P. A.
    HIV MEDICINE, 2011, 12 (04) : 250 - 254
  • [32] Effects of M184V mutation in multi-dideoxynucleoside analog resistant HIV-1 reverse transcriptase on removal of β-D-dioxolane-guanine monophosphate from blocked primer
    Lennerstrand, J
    Espili, NH
    Pavlova, A
    Chu, CK
    Asif, G
    Schinazi, RF
    ANTIVIRAL THERAPY, 2005, 10 : S79 - S79
  • [33] Effects of M184V mutation in multi-dideoxynucleoside analog resistant HIV-1 reverse transcriptase on removal of β-D-dioxolane-guanine monophosphate from blocked primer
    Lennerstrand, J
    Espili, NH
    Pavlova, A
    Chu, CK
    Asif, G
    Schinazi, RF
    ANTIVIRAL THERAPY, 2005, 10 (04) : S79 - S79
  • [34] BIOLOGICAL AND ENZYMATIC STUDIES ON THE FIDELITY OF WILD-TYPE AND MUTATED HIV-1 REVERSE-TRANSCRIPTASE
    WAINBERG, MA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S169 - S169
  • [35] Single-step purification of recombinant wild-type and mutant HIV-1 reverse transcriptase
    Fletcher, RS
    Holleschak, G
    Nagy, E
    Arion, D
    Borkow, G
    Gu, ZX
    Wainberg, MA
    Parniak, MA
    PROTEIN EXPRESSION AND PURIFICATION, 1996, 7 (01) : 27 - 32
  • [36] QSAR studies for diarylpyrimidines against HIV-1 reverse transcriptase wild-type and mutant strains
    Liang, Yong-Hong
    Chen, Fen-Er
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) : 625 - 631
  • [37] Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine
    Murry, JP
    Higgins, J
    Matthews, TB
    Huang, VY
    Van Rompay, KKA
    Pedersen, NC
    North, TW
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1120 - 1130
  • [38] Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1
    Inouye, P
    Cherry, E
    Hsu, M
    Zolla-Pazner, S
    Wainberg, MA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (09) : 735 - 740
  • [39] Entecavir therapy induces de novo HIV reverse-transcriptase M184V mutation in an antiretroviral therapy-naive patient
    Jakobsen, Martin R.
    Arildsen, Hanne
    Krarup, Henrik B.
    Tolstrup, Martin
    Ostergaard, Lars
    Laursen, Alex L.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (09) : E88 - E91
  • [40] New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)
    Pouga, Lydia
    Santoro, Maria Mercedes
    Charpentier, Charlotte
    Di Carlo, Domenico
    Romeo, Isabella
    Artese, Anna
    Alcaro, Stefano
    Antinori, Andrea
    Wirden, Marc
    Perno, Carlo Federico
    Ambrosio, Francesca Alessandra
    Calvez, Vincent
    Descamps, Diane
    Marcelin, Anne-Genevieve
    Ceccherini-Silberstein, Francesca
    Lambert-Niclot, Sidonie
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (01) : 50 - 59